Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3. This indicates a routine platform update that updates internal versioning rather than study information.SummaryDifference0.1%

- Check18 days agoChange DetectedThe study's Indiana-based affiliation was updated from Indiana University School of Medicine to Indiana University, changing the credited institution in the collaborators/locations section. This reflects a broader institutional naming for the site and may affect how the record is identified in communications and databases.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s revision/build indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check40 days agoChange DetectedFooter revision label updated from Revision: v3.5.0 to Revision: v3.5.2. This indicates a minor site maintenance update with no changes to study content or data visible on the page.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.